Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants
Conditions: Elder Interventions: Drug: Leritrelvir Sponsors: Guangdong Raynovent Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
SG2918 For Advanced Malignant Tumors
Conditions: Advanced Malignant Tumors Interventions: Drug: SG2918 Sponsors: Hangzhou Sumgen Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
Conditions: Intermittent Claudication Interventions: Drug: Cilostazol Tablet 100 mg; Drug: PMR Tablet 145 mg Sponsors: Genovate Biotechnology Co., Ltd., Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Conditions: Ocular Inflammation in Subjects Undergoing Cataract Surgery Interventions: Drug: VVN461 Ophthalmic Solution 1.0%; Drug: VVN461 Ophthalmic Solution 0.5%; Drug: Vehicle Sponsors: VivaVision Biotech, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273
Conditions: Bioequivalence Interventions: Drug: ZSP1273 tablet; Drug: zsp1273 granules Sponsors: Guangdong Raynovent Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy Study of hAESCs Therapy for aGVHD
Conditions: GVHD,Acute Interventions: Drug: Human Amniotic Epithelial Stem Cell Injection Sponsors: Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
Conditions: Gaucher Disease Type I Interventions: Biological: LY-M001 Injection Sponsors: He Huang; Lingyi Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer
Conditions: Advanced Solid Tumor; Metastatic Solid Tumor Interventions: Drug: SOT201 Sponsors: SOTIO Biotech AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Vesper Bio doses first volunteer in Phase I study of first-in-class oral treatment for Frontotemporal Dementia
COPENHAGEN, Denmark, Dec. 7, 2023. Vesper Bio ApS ( " Vesper " or " the Company " ), a clinical stage biotech and world leader in sortilin receptor biology, today announces that the first volunteer has been dosed with its lead compound VES001, a patient... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 7, 2023 Category: Pharmaceuticals Source Type: clinical trials
Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease
Conditions: Kidney Impairment Interventions: Drug: Leritrelvir Sponsors: Guangdong Raynovent Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic Impairment
Conditions: Hepatic Impairment Interventions: Drug: Leritrelvir(Ray1216) Sponsors: Guangdong Raynovent Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
SAN JOSE, Calif., Dec. 6, 20203. Anixa Biosciences ( " Anixa " or the " Company " ), a biotechnology company focused on the treatment and prevention of cancer, today announced new and updated positive results from the Phase 1 clinical trial of its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 7, 2023 Category: Pharmaceuticals Source Type: clinical trials
Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors
WALTHAM, Mass., Dec. 5, 2023. Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced it recently dosed its first patient in a Phase 1/1b study of the Company ' s proprietary IL-2... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 6, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects
Conditions: Healthy Male Volunteers Interventions: Drug: HLX13; Drug: CN-sourced ipilimumab; Drug: EU-sourced ipilimumab group; Drug: US-sourced ipilimumab group Sponsors: Shanghai Henlius Biotech Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Pharmacokinetics of ZSP1273 in Elder Participants
Conditions: Elder Interventions: Drug: ZSP1273 Sponsors: Guangdong Raynovent Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
